Patent ID: 11866446
Assignee: VERTEX PHARMACEUTICALS INCORPORATED
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 28:
29. The compound, tautomer, deuterated derivative, or pharmaceutically acceptable salt according to claim 1, wherein Ra, for each occurrence, is independently selected from F, cyano, —OH, —CH3, —CF3, —CH(CH3)2, —(CH2)2OH, —(CH2)2OCH3, —CH2CH(OH)C2H5, —CH2C(CH3)(CH2OH)2, —OCH3, —OCH2CH3, —[O(CH2)2]2OCH3, —CH2C(═O)NHCH3, —(CH2)2SO2CH3, CH2C(═O)N(CH3)2, —CH2(cyclopropyl), —C(═O)NH2, —C(═O)NH(cyclopropyl), —NH2, —NHCH3, —N(CH3)2, —NHC(CH3)2CH2OH, —NHC(═O)CH3, —SO2CH3, —SO2NH2, cyclopropyl, 2-methoxyphenyl,, N-methylpiperazinyl, tetrahydro-2H-pyranyl, methylpyrazolyl, pyridinyl, and tetrahydrothiophenyl 1,1-dioxide.